• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

揭示天然产物诱导免疫原性细胞死亡的机制:开启肿瘤免疫治疗新篇章。

Revealing the mechanism of natural product-induced immunogenic cell death: opening a new chapter in tumor immunotherapy.

机构信息

Department of Oncology, Dong Fang Hospital, Beijing University of Chinese Medicine, Beijing, China.

Acupuncture and Tuina School, Chengdu University of Traditional Chinese Medicine, Chengdu, China.

出版信息

Front Immunol. 2024 Oct 9;15:1470071. doi: 10.3389/fimmu.2024.1470071. eCollection 2024.

DOI:10.3389/fimmu.2024.1470071
PMID:39445013
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11496055/
Abstract

This review underscores the role of natural products in inducing immunogenic cell death (ICD) as a key strategy in tumor immunotherapy. It reveals that natural products can activate ICD through multiple pathways-apoptosis, autophagy, pyroptosis, and necroptosis-leading to the release of danger-associated molecular patterns (DAMPs), dendritic cell activation, and improved antigen presentation, which together stimulate a potent anti-tumor immune response. The study also demonstrates the enhanced therapeutic potential of combining natural products with immune checkpoint inhibitors. With a focus on translating preclinical findings into clinical practice, this review consolidates recent discoveries and suggests future research paths, offering both theoretical insights and practical guidance for advancing cancer immunotherapy.

摘要

这篇综述强调了天然产物在诱导免疫原性细胞死亡(ICD)中的作用,这是肿瘤免疫治疗的一个关键策略。它揭示了天然产物可以通过多种途径——凋亡、自噬、细胞焦亡和坏死性凋亡——激活 ICD,导致危险相关分子模式(DAMPs)的释放、树突状细胞的激活和抗原呈递的改善,从而共同刺激强烈的抗肿瘤免疫反应。该研究还表明,将天然产物与免疫检查点抑制剂联合使用可以增强治疗潜力。本综述侧重于将临床前研究结果转化为临床实践,总结了最近的发现,并提出了未来的研究方向,为推进癌症免疫治疗提供了理论见解和实用指导。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15bc/11496055/c533538242bf/fimmu-15-1470071-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15bc/11496055/e4a2bc11d624/fimmu-15-1470071-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15bc/11496055/939e4b90fb65/fimmu-15-1470071-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15bc/11496055/c533538242bf/fimmu-15-1470071-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15bc/11496055/e4a2bc11d624/fimmu-15-1470071-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15bc/11496055/939e4b90fb65/fimmu-15-1470071-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15bc/11496055/c533538242bf/fimmu-15-1470071-g003.jpg

相似文献

1
Revealing the mechanism of natural product-induced immunogenic cell death: opening a new chapter in tumor immunotherapy.揭示天然产物诱导免疫原性细胞死亡的机制:开启肿瘤免疫治疗新篇章。
Front Immunol. 2024 Oct 9;15:1470071. doi: 10.3389/fimmu.2024.1470071. eCollection 2024.
2
Immunogenic cell death inducers for cancer therapy: An emerging focus on natural products.免疫原性细胞死亡诱导剂在癌症治疗中的应用:天然产物的新焦点。
Phytomedicine. 2024 Sep;132:155828. doi: 10.1016/j.phymed.2024.155828. Epub 2024 Jun 13.
3
Natural Compounds of Marine Origin as Inducers of Immunogenic Cell Death (ICD): Potential Role for Cancer Interception and Therapy.海洋来源天然化合物作为免疫原性细胞死亡(ICD)诱导剂:在癌症阻断和治疗中的潜在作用。
Cells. 2021 Jan 25;10(2):231. doi: 10.3390/cells10020231.
4
Nanomicelle protects the immune activation effects of Paclitaxel and sensitizes tumors to anti-PD-1 Immunotherapy.纳米胶束保护紫杉醇的免疫激活作用,并使肿瘤对抗 PD-1 免疫治疗敏感。
Theranostics. 2020 Jul 9;10(18):8382-8399. doi: 10.7150/thno.45391. eCollection 2020.
5
Emerging role of immunogenic cell death in cancer immunotherapy.免疫原性细胞死亡在癌症免疫治疗中的新作用。
Front Immunol. 2024 May 10;15:1390263. doi: 10.3389/fimmu.2024.1390263. eCollection 2024.
6
Plant-derived natural compounds: A new frontier in inducing immunogenic cell death for cancer treatment.植物源天然化合物:诱导免疫原性细胞死亡治疗癌症的新前沿。
Biomed Pharmacother. 2024 Aug;177:117099. doi: 10.1016/j.biopha.2024.117099. Epub 2024 Jul 8.
7
Nanoparticle-mediated immunogenic cell death for cancer immunotherapy.纳米颗粒介导的免疫原性细胞死亡用于癌症免疫治疗。
Int J Pharm. 2024 May 10;656:124045. doi: 10.1016/j.ijpharm.2024.124045. Epub 2024 Mar 30.
8
Targeted delivery of anti-miRNA21 sensitizes PD-L1 tumor to immunotherapy by promoting immunogenic cell death.靶向递送抗 miRNA21 通过促进免疫原性细胞死亡使 PD-L1 肿瘤对免疫治疗敏感。
Theranostics. 2024 Jun 17;14(10):3777-3792. doi: 10.7150/thno.97755. eCollection 2024.
9
Sensitize Tumor Immunotherapy: Immunogenic Cell Death Inducing Nanosystems.致敏肿瘤免疫治疗:免疫原性细胞死亡诱导纳米系统。
Int J Nanomedicine. 2024 Jun 13;19:5895-5930. doi: 10.2147/IJN.S457782. eCollection 2024.
10
Natural modulators of the hallmarks of immunogenic cell death.免疫原性细胞死亡特征的天然调节剂。
Biochem Pharmacol. 2019 Apr;162:55-70. doi: 10.1016/j.bcp.2018.12.016. Epub 2019 Jan 5.

本文引用的文献

1
Emerging role of immunogenic cell death in cancer immunotherapy.免疫原性细胞死亡在癌症免疫治疗中的新作用。
Front Immunol. 2024 May 10;15:1390263. doi: 10.3389/fimmu.2024.1390263. eCollection 2024.
2
Targeting immunogenic cell stress and death for cancer therapy.针对免疫原性细胞应激和死亡的癌症治疗。
Nat Rev Drug Discov. 2024 Jun;23(6):445-460. doi: 10.1038/s41573-024-00920-9. Epub 2024 Apr 15.
3
Augmenting Cancer Therapy with a Supramolecular Immunogenic Cell Death Inducer: A Lysosome-Targeted NIR-Light-Activated Ruthenium(II) Metallacycle.
用超分子免疫原性细胞死亡诱导剂增强癌症治疗:一种溶酶体靶向近红外光激活钌(II)金属络合物。
J Am Chem Soc. 2024 Apr 3;146(13):8991-9003. doi: 10.1021/jacs.3c13224. Epub 2024 Mar 21.
4
Immunogenic cell death in cancer: targeting necroptosis to induce antitumour immunity.肿瘤中的免疫原性细胞死亡:靶向坏死性凋亡诱导抗肿瘤免疫。
Nat Rev Cancer. 2024 May;24(5):299-315. doi: 10.1038/s41568-024-00674-x. Epub 2024 Mar 7.
5
Immunotherapy resistance in solid tumors: mechanisms and potential solutions.实体瘤免疫治疗耐药:机制与潜在解决方案。
Cancer Biol Ther. 2024 Dec 31;25(1):2315655. doi: 10.1080/15384047.2024.2315655. Epub 2024 Feb 22.
6
Preconditioning with immunogenic cell death-inducing treatments for subsequent immunotherapy.用诱导免疫细胞死亡的预处理治疗方法为后续免疫治疗做准备。
Int Rev Cell Mol Biol. 2024;382:279-294. doi: 10.1016/bs.ircmb.2023.06.001. Epub 2023 Jul 26.
7
Arsenic trioxide: applications, mechanisms of action, toxicity and rescue strategies to date.三氧化二砷:应用、作用机制、毒性及迄今的抢救策略。
Arch Pharm Res. 2024 Mar;47(3):249-271. doi: 10.1007/s12272-023-01481-y. Epub 2023 Dec 26.
8
Glutathione Consumptive Dual-Sensitive Lipid-Composite Nanoparticles Induce Immunogenic Cell Death for Enhanced Breast Tumor Therapy.谷胱甘肽消耗型双敏脂质复合纳米粒诱导免疫原性细胞死亡增强乳腺癌治疗。
Mol Pharm. 2024 Jan 1;21(1):113-125. doi: 10.1021/acs.molpharmaceut.3c00518. Epub 2023 Dec 11.
9
An immunogenic cell death-related signature for prediction of prognosis and response to immunotherapy in breast cancer.一种用于预测乳腺癌预后及免疫治疗反应的免疫原性细胞死亡相关特征。
Chin Med J (Engl). 2024 Feb 20;137(4):487-489. doi: 10.1097/CM9.0000000000002862. Epub 2023 Nov 21.
10
Using immunogenic cell death to improve anticancer efficacy of immune checkpoint inhibitors: From basic science to clinical application.利用免疫原性细胞死亡提高免疫检查点抑制剂的抗癌疗效:从基础科学到临床应用。
Immunol Rev. 2024 Jan;321(1):335-349. doi: 10.1111/imr.13263. Epub 2023 Aug 18.